- About
- IgAN
- Events
- Resource Center
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives
The Role Of The Pharmacist In Chronic Kidney Disease Test #2
Thank you for attending, we hope you enjoyed this webinar.
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
The Role Of The Pharmacist In Chronic Kidney Disease Test #2
Clinical pharmacy services have the potential to contribute significantly to the multidisciplinary team by providing safe, effective, and economic care for patients. Given recent practice developments (e.g. polypharmacy reviews and pharmacist prescribing), there is a need to provide a current synthesis of evidence-based characteristics and outcomes of clinical pharmacy practice in treating patients with chronic kidney disease (CKD). Dr. Calvin Meaney and Dr. Katie Cardone outline the role of both inpatient and outpatient clinical pharmacy services as well as discuss medication therapy challenges in managing patients with CKD.
Featuring
Calvin J. Meaney, PharmD, BCPS
Clinical Associate Professor, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences-
University at Buffalo*
Dr. Meaney is a Clinical Associate Professor in the Department of Pharmacy Practice at the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. He received his Doctor of Pharmacy from the University at Buffalo, followed by residency training at the University of Maryland Medical Center and fellowship in clinical pharmacology back at the University at Buffalo. He is clinical pharmacist-scientist in the field of nephrology. His clinical practice is at the Erie County Medical Center, the Regional Center of Excellence in Transplantation in Kidney Care, where he precepts pharmacy students and residents. Dr. Meaney‘s research is focused on the optimization of drug therapy through the application of quantitative clinical pharmacology. He leads multidisciplinary research groups focused on anemia in chronic kidney disease and drug-induced nephrotoxicity.
Katie E. Cardone, BCACP, FNKF, FASN, FCCP
Associate Professor of Pharmacy Practice, Interim Director, Doctor of Pharmacy Program, Director of Clinical Pharmacy Services, The Collaboratory, Residency Program Director, PGY2 Ambulatory Care-
Albany College of Pharmacy and Health Sciences*
Katie Cardone is an associate professor and pharmacy program director in the Department of Pharmacy Practice at Albany College of Pharmacy and Health Sciences. She received her doctor of pharmacy degree from Albany College of Pharmacy and subsequently completed a fellowship in nephrology pharmacy at Albany Medical Center and Albany College of Pharmacy. Dr. Cardone has had clinical practice sites in dialysis and outpatient nephrology for over a decade and serves as the director of clinical pharmacy services at The Collaboratory, a public health outreach office housing community health workers and a public health pharmacy team. She serves as residency program director for the College’s PGY2 ambulatory care residency. Her research program focuses on optimizing medication outcomes in patients with kidney disease. Dr. Cardone a board certified ambulatory care pharmacist and is a fellow of the National Kidney Foundation, the American Society of Nephrology and the American College of Clinical Pharmacy.
Lisa Voigt, PharmD, BCPS, BCCCP
Nephrology Senior Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Lisa Voigt, PharmD, BCPS, BCCCP is a PharmD who works as a Senior Medical Science Liaison in Nephrology with Otsuka Pharmaceutical Development & Commercialization, Inc. Prior to joining Otsuka in 2019, Dr Voigt practiced as a Medical Intensive Care Unit and Surgical Intensive Care Unit Pharmacist for 15 years at a tertiary medical center in Buffalo, NY. She earned her Bachelor of Science degree in Pharmaceutics and PharmD from the SUNY Buffalo School of Pharmacy and Pharmaceutical Sciences. She completed a Post-Graduate year 1 Pharmacy Residency and Post-Graduate year 2 Critical Care/Emergency Medicine Pharmacy Residency at the University of Rochester Medical Center in Rochester, NY. Dr Voigt is a Past-President of the New York State Council of Health-system Pharmacists and has served on the Board of Directors for the past 10 years. She is also Past-President of the Western New York Society of Health-system Pharmacists. She is an Adjunct Assistant Professor at SUNY Buffalo, School of Pharmacy and Pharmaceutical Sciences. Dr Voigt holds board certifications in pharmacotherapy as well as critical care pharmacotherapy.
*Dr Meaney and Ms Cardone are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Voigt is an employee of OPDC.
Registration
-
Utilization of the International IgA Nephropathy Prediction Tool
Learn about the clinical, laboratory and histological risk predictors that make up the International IgAN Prediction Tool and gain an understanding of its clinical utility and future potential.
Related Events
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2024 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved. - IgAN
